Steven Davidoff Solomon and Peter J. Henning write for The New York Times, November 6, 2014
“For those keeping score in the hostile battle for control over the Botox maker Allergan, the latest court ruling is a mixed bag.”
Steven Davidoff Solomon and Peter J. Henning write for The New York Times, November 6, 2014
“For those keeping score in the hostile battle for control over the Botox maker Allergan, the latest court ruling is a mixed bag.”